Iguratimod attenuated fibrosis in systemic sclerosis via targeting early growth response 1 expression.
Arthritis Res Ther
; 25(1): 151, 2023 08 18.
Article
in En
| MEDLINE
| ID: mdl-37596660
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Scleroderma, Systemic
/
Antirheumatic Agents
/
Early Growth Response Protein 1
Type of study:
Prognostic_studies
Limits:
Animals
/
Humans
Language:
En
Journal:
Arthritis Res Ther
Year:
2023
Document type:
Article